je.st
news
Home
› Proteostasis Therapeutics Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics For Novel Therapies Targeting Most Common CF Mutation
Proteostasis Therapeutics Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics For Novel Therapies Targeting Most Common CF Mutation
2014-03-05 04:23:36| drugdiscoveryonline News Articles
Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, recently announced an extension of its funded collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT)
Tags: common
foundation
extension
collaboration
Category:Biotechnology and Pharmaceuticals